Mayo Clinic testing Israeli magnetic-heating technology as cancer treatment

February 18, 2026 - 13:46

The Mayo Clinic has become the first medical institution in the United States to begin clinical testing of a novel cancer treatment that uses targeted magnetic heat to destroy tumors. This innovative technology, developed in Israel, represents a new frontier in the fight against cancer.

The system employs an induction-based approach, generating extreme heat directly within cancer cells. This process, known as magnetic hyperthermia, involves injecting tiny magnetic particles into a tumor. An external magnetic field is then applied, causing the particles to vibrate and rapidly heat up. The resulting intense heat selectively kills the cancerous cells while aiming to spare the surrounding healthy tissue.

This targeted strategy offers a potential alternative or complement to existing treatments like chemotherapy and radiation, which can have widespread effects on the body. The precision of the magnetic-heating technique could lead to fewer side effects for patients and provide a new option for hard-to-treat tumors.

Initial testing at Mayo Clinic is focused on evaluating the safety and feasibility of the technology. While still in early stages, this pioneering trial marks a significant step toward integrating this advanced form of thermal therapy into the oncological toolkit, potentially offering new hope for patients in the future.